approval
saveVALPROATE SODIUM — FDA approval
community read0 votes
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 2 completionAustralasian Gastro-Intestinal Trials Group — valproate sodium (Phase II Trial Completion)Apr 30, 2026 · 155d ago
- approvalVALPROATE SODIUM — FDA approvalMar 31, 2026 · 185d ago
- approvalVALPROATE SODIUM — FDA approvalApr 4, 2024 · 911d ago
- approvalVALPROATE SODIUM — FDA approvalApr 4, 2024 · 911d ago
- approvalVALPROATE SODIUM — FDA approvalOct 11, 2016 · 3643d ago
- approvalVALPROATE SODIUM — FDA approvalDec 22, 2015 · 3937d ago
- approvalVALPROATE SODIUM — FDA approvalDec 22, 2015 · 3937d ago
- approvalVALPROATE SODIUM — FDA approvalDec 22, 2015 · 3937d ago
same company · ±60 days · 6
- approvalSaxenda: LIRAGLUTIDE — FDA approvalMar 30, 2026
- approvalEPHEDRINE SULFATE: EPHEDRINE SULFATE — FDA approvalMar 19, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
🐶 often sniffed alongside
top 7- tagApproval56 co-mentions · 28 sources
- drugRNS-6010 co-mentions · 10 sources
- companyFresenius Kabi USA LLC10 co-mentions · 10 sources
- tagOncology3 co-mentions · 1 sources
- tagColorectal Cancer2 co-mentions · 1 sources
- companyAustralasian Gastro-Intestinal Trials Group1 co-mentions · 1 sources
- tagGastroenterology1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that